Skip to main content
. Author manuscript; available in PMC: 2017 Jul 18.
Published in final edited form as: JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):18–26. doi: 10.1001/jamaoto.2014.2669

Table 1.

Description of Study Population at Baseline

Characteristic Placebo and Cognitive
Training
(n = 14)
D-Cycloserine and Cognitive
Training
(n = 16)
P Value
Demographic characteristics
  Age, median (range), y 55 (37–63) 59 (49–63) .06
  Female sex, No. (%) 6 (43) 8 (50) .70
  Race, No. (%)
    White 11 (79) 16 (100) .09
    Other 3 (21) 0
  Education, median (range), y 17 (14–18) 16 (12–20) .39
Tinnitus characteristics at baseline
  Duration of tinnitus, median (range), y 10.0 (5–57) 4.8 (1–37) .047
  Subjective loudness, median (range) 6 (4–10) 7 (3–9) .85
  Effort to ignore, No. (%)
    Can never ignore 3 (21) 3 (19) .48
    Considerable effort 1 (7) 2 (12)
    Some effort 10 (71) 8 (50)
    Slight effort 0 3 (19)
  TFI score, median (range) 44 (14–65) 47 (10–76) .66
  Bother level, No. (%)
    Extremely bothered 0 0 .46
    Bothered a lot 4 (29) 6 (38)
    Bothered more than a little but not a lot 8 (57) 10 (63)
    Bothered a little, but not much 2 (14) 0
    Not bothered 0 0
  PHQ-9 score, median (range) 4 (0–10) 5 (1–11) .74
  Cognitive assessments, median (range)
    CFQ score 43 (19–60) 41 (18–51) .85
    Stroop Color-Word T-score 58 (43–64) 54 (40–71) .28
    PASAT, No. correct 156 (68–194) 128 (65–229) .48

Abbreviations: CFQ, Cognitive Failures Questionnaire; PASAT, Paced Auditory Serial Addition Test; PHQ-9, Patient Health Questionnaire-9; TFI, Tinnitus Functional Index.